Why Order a Coombs Test for Hereditary Spherocytosis?
At a Glance
A Coombs test (DAT) is ordered when hereditary spherocytosis is suspected to rule out autoimmune hemolytic anemia (AIHA). Both conditions cause identical round red blood cells called spherocytes. A negative Coombs test rules out an autoimmune attack, helping confirm a genetic diagnosis.
In this answer
3 sections
If your doctor suspects you have hereditary spherocytosis (HS), it can be confusing and alarming to see them order a Coombs test — also known as a Direct Antiglobulin Test or DAT [1]. The Coombs test looks for antibodies that attack your red blood cells, which is the hallmark of an autoimmune disorder [2]. You might wonder: If they think I have a genetic condition, why are they testing me for an autoimmune disease?
The answer comes down to what your red blood cells look like under a microscope.
The Case of the Identical Spherocytes
When a hematologist looks at your blood smear, they are looking for spherocytes. These are red blood cells that have lost their typical donut-like shape and instead look like small, perfectly round spheres.
While spherocytes are the defining feature of hereditary spherocytosis, HS is not the only condition that causes them. Spherocytes are also a classic sign of Autoimmune Hemolytic Anemia (AIHA) [1].
In AIHA, your immune system mistakenly produces antibodies that attach to healthy red blood cells [3]. As these antibody-coated cells travel through your spleen, the spleen “bites” off portions of the cell membrane, turning them into spheres. In contrast, in HS, the spherocytes are caused by an inherited genetic defect in the structural proteins of the cell membrane itself [4][5], not by an immune system attack.
Because the spherocytes from HS and AIHA look completely identical under a microscope, your doctor needs a way to tell them apart.
What the Coombs Test Tells Your Doctor
The Coombs test (DAT) is a standard blood test used to definitively distinguish between these two very different conditions [1][6]:
- A Positive Coombs Test: This means antibodies were detected on your red blood cells. This points to Autoimmune Hemolytic Anemia (AIHA) as the cause of your spherocytes and anemia [3][1].
- A Negative Coombs Test: This means no antibodies were detected on your red blood cells. A negative result usually rules out AIHA and strongly supports the diagnosis of a genetic structural issue, like hereditary spherocytosis [7].
Once a negative Coombs test helps rule out an autoimmune cause, your doctor will likely proceed with specific tests to officially confirm hereditary spherocytosis, such as an EMA binding test or an osmotic fragility test [7][8].
Why Getting the Diagnosis Right Matters
Even though HS and AIHA both cause spherocytes and hemolytic anemia (the premature destruction of red blood cells), they are treated very differently. AIHA is typically treated with medications that suppress the immune system, such as steroids [9][10]. Hereditary spherocytosis, being a genetic structural issue, does not respond to steroids or immunosuppressants. Instead, HS is managed through monitoring, folic acid supplementation, and in some cases, surgical removal of the spleen (splenectomy) [11][12].
By running a Coombs test, your doctor is simply being thorough. A negative result provides the necessary confirmation that your immune system is working normally, allowing your care team to safely proceed with confirming and treating hereditary spherocytosis [7].
Common questions in this guide
What does a negative Coombs test mean for hereditary spherocytosis?
Why do hereditary spherocytosis and autoimmune hemolytic anemia look the same?
What tests are done after a negative Coombs test?
Why is it so important to distinguish between HS and AIHA?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my negative Coombs test completely rule out all autoimmune causes for my anemia, or are there rare cases we should still consider?
- 2.Now that we are investigating a genetic cause, will we be doing an EMA binding test or osmotic fragility test next to confirm hereditary spherocytosis?
- 3.Can you explain my other lab results, like my reticulocyte count and bilirubin levels, in the context of my suspected HS?
- 4.Will any of my immediate family members need to be tested for hereditary spherocytosis once my diagnosis is confirmed?
- 5.Are there any specific precautions I should take or symptoms I should watch for while we finalize my diagnosis?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist.
Fattizzo B, Giannotta JA, Serpenti F, Barcellini W
Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9123858.
PMID: 33261016 - 2
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
Loriamini M, Cserti-Gazdewich C, Branch DR
International journal of molecular sciences 2024; (25(8)) doi:10.3390/ijms25084296.
PMID: 38673882 - 3
The Clinical Pictures of Autoimmune Hemolytic Anemia.
Packman CH
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2015; (42(5)):317-24 doi:10.1159/000440656.
PMID: 26696800 - 4
Clinical Characteristics and Gene Mutations of Hereditary Spherocytosis in 59 Chinese Children.
Li Y, Wang Y, Liu T, et al.
Molecular genetics & genomic medicine 2026; (14(3)):e70188 doi:10.1002/mgg3.70188.
PMID: 41721551 - 5
Analysis of erythrocyte membrane proteins in patients with hereditary spherocytosis and other types of haemolytic anaemia.
Shibuya A, Kawashima H, Tanaka M
Hematology (Amsterdam, Netherlands) 2018; (23(9)):669-675 doi:10.1080/10245332.2018.1455278.
PMID: 29623813 - 6
Autoimmune Hemolytic Anemia.
Liebman HA, Weitz IC
The Medical clinics of North America 2017; (101(2)):351-359 doi:10.1016/j.mcna.2016.09.007.
PMID: 28189175 - 7
Advances in laboratory diagnosis of hereditary spherocytosis.
Farias MG
Clinical chemistry and laboratory medicine 2017; (55(7)):944-948.
PMID: 27837594 - 8
Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
Arora RD, Dass J, Maydeo S, et al.
International journal of laboratory hematology 2018; (40(3)):335-342 doi:10.1111/ijlh.12794.
PMID: 29573337 - 9
Practical therapy for primary autoimmune hemolytic anemia in adults.
Fatone MC, Cirasino L
Clinical and experimental medicine 2023; (23(3)):727-736 doi:10.1007/s10238-022-00869-2.
PMID: 35980482 - 10
Canine autoimmune hemolytic anemia: management challenges.
Swann JW, Skelly BJ
Veterinary medicine (Auckland, N.Z.) 2016; (7()):101-112 doi:10.2147/VMRR.S81869.
PMID: 30050843 - 11
Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis.
Zaninoni A, Vercellati C, Imperiali FG, et al.
Transfusion 2015; (55(12)):2930-8 doi:10.1111/trf.13257.
PMID: 26259504 - 12
Biomechanics of red blood cells in human spleen and consequences for physiology and disease.
Pivkin IV, Peng Z, Karniadakis GE, et al.
Proceedings of the National Academy of Sciences of the United States of America 2016; (113(28)):7804-9 doi:10.1073/pnas.1606751113.
PMID: 27354532
This page is for informational purposes only and does not replace professional medical advice. Always consult your hematologist or primary care provider to discuss your specific lab results and diagnosis.
Get notified when new evidence is published on Hereditary spherocytosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.